Skip to main content

Table 4 The PK profiles of PF-06840003

From: Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy

Species

CL (mL/min/kg)

Vss (L/kg)

t1/2 (h)

F (%)

AUC (ng h/mL)

Rat

3.7

0.639

2.42

94.0

6940

Dog

24.3

0.957

0.840

18.6

237

Human

0.64

1.1

19

64

ND

  1. CL, plasma clearance; Vss, volume distribution stead state; t1/2, half-life; F, Oral bioavailability; AUC, area under the concentration-time curve